Format

Send to

Choose Destination
See comment in PubMed Commons below
Plasmid. 2013 May;69(3):223-30. doi: 10.1016/j.plasmid.2013.01.004. Epub 2013 Feb 1.

CMV promoter is repressed by p53 and activated by JNK pathway.

Author information

1
Laboratory of Biochemistry, Garrett-Strong Science Building 3100, Northwest Missouri State University, Maryville, MO 64468, USA.

Abstract

Viral promoters are widely utilized in commercial and customized vectors to drive expression of genes of interest including reporter, effector and transfection control, because of their high transcription efficiency in a variety of primary and transformed cell lines. However, we observed altered rate of transcription for these promoters under conditions such as presence of an effector protein. These variations in viral promoter driven expressions can potentially lead to incorrect conclusion, especially in comparative and quantitative experiments. We found significantly reduced viral promoter activity in cells overexpressing tumor suppressor protein p53, whereas markedly induced transcription in cells overexpressing MAP/ERK kinase kinase 1 (Mekk 1). Using deletion constructs generated from the CMV promoter, we found the transcription reduction by p53 is possibly mediated through the TATA motif present in proximal CMV promoter. The activation of the CMV promoter by Mekk 1, on the other hand, is attributed to the proximal CRE binding site in the promoter. These findings may be of interest to investigators who use CMV (or other viral) promoter driven vectors for either comparative or quantitative gene expression, or effect on promoter activity.

PMID:
23376463
PMCID:
PMC3650106
DOI:
10.1016/j.plasmid.2013.01.004
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center